Profile
Lightstone Ventures is a venture capital firm founded in 2012, with offices in Portola Valley, California, and Dublin, Ireland. The firm is led by a team with nearly 100 years of combined experience in company-building, focusing on healthcare and life sciences. They are known for their hands-on approach, partnering with founders to transform innovative ideas into commercially viable products.
Lightstone Ventures invests in biotech and medtech sectors, targeting companies developing first-in-class drugs and groundbreaking medical technologies. They focus on areas such as oncology, immunology, and ophthalmology, with a global investment reach including Europe and Australia. The firm typically invests in early to late-stage companies and has a portfolio that includes notable exits and IPOs.
Notable investments by Lightstone Ventures include Ardian - medical devices, Acceleron - biopharmaceuticals, ALX Oncology - cancer therapeutics, Calithera BioSciences - oncology, and Disarm Therapeutics - neurology. These investments highlight their commitment to advancing healthcare innovations.
Industry
Lightstone Ventures Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Lightstone Ventures I LP
|
Venture Capital (VC)
|
Food and Beverage
Foodtech
Healthcare Services
Robotics
SaaS
Security
Software
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$172 M
|
April 2014
|
|
Lightstone Singapore, L.P.
|
Venture Capital (VC)
|
Financial Services
Fintech
Food and Beverage
Foodtech
Healthcare Services
SaaS
Security
Software
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$50 M
|
February 2016
|
|
Lightstone Ventures III
|
Venture Capital (VC)
|
Food and Beverage
Foodtech
Healthcare Services
SaaS
Security
Software
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$375 M
|
September 2021
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.